Add BrightSurf on Google Email

Hallucinogen use linked to 2.6-fold increase in risk of death for people needing emergency care

A new study found that people seeking emergency care for hallucinogen use were at a 2.6-fold higher risk of death within 5 years compared to the general population. The increased risk was highest among individuals with medical comorbidities and those from low-income neighborhoods.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeObservational study·DateMar 3, 2025

TTUHSC conducting study to help patients that experience traumatic blood loss

The Texas Tech University Health Sciences Center is conducting a randomized controlled trial to investigate the effectiveness of calcium and vasopressin in treating severely injured patients who experience significant blood loss. The study, known as CAVALIER, will enroll approximately 1,050 participants aged 18-90.

SourceTexas Tech University Health Sciences Center·TypeRandomized controlled/clinical trial·DateFeb 28, 2025

Unraveling the molecular mechanisms of tumor metastasis: Insights and therapeutic strategies

The review delves into genetic, epigenetic, and molecular mechanisms driving tumor metastasis, highlighting the roles of chromosomal instability, epigenetic modifications, and tumor microenvironment interactions. It also discusses the impact of specific genetic mutations and RNA modifications on metastatic behavior.

Research suggests common viral infection worsens deadly condition among premature babies

Researchers found that cytomegalovirus infection significantly worsens necrotizing enterocolitis in mouse models, triggering inflammation and disrupting energy production. The study provides insight into the underlying mechanisms of NEC and may lead to the development of new treatments for this devastating condition.

SourceJohns Hopkins Medicine·JournalCellular and Molecular Gastroenterology and Hepatology·DateFeb 24, 2025

Ivermectin, hydroxychloroquine prescriptions during the COVID-19 pandemic soared far above pre-pandemic levels

US outpatient prescriptions for ivermectin and hydroxychloroquine increased significantly during the COVID-19 pandemic, with usage being three times higher among adults aged 65 and older. The study's findings highlight the need for policy reforms to combat misinformation and mistrust in scientific institutions.

SourceUniversity of California - Los Angeles Health Sciences·JournalHealth Affairs·TypeData/statistical analysis·DateFeb 20, 2025

Biologists transform gut bacteria into tiny protein pharmacies

Researchers at Virginia Tech have developed a method to convert gut bacteria into mini protein factories that produce and release sustained flows of targeted proteins within the lower intestine. This approach eliminates a major roadblock in delivering drugs to this part of the body, offering potential treatment for chronic diseases.

SourceVirginia Tech·JournalNature·DateFeb 18, 2025

New discovery could help protect against influenza

A preclinical trial has uncovered how beta-glucan can 'reprogram' immune cells to prevent lung inflammation and reduce the risk of illness and death from influenza. The study's findings highlight beta-glucan as a promising therapy for influenza and other emerging viral pathogens.

SourceMcGill University·JournalNature Immunology·TypeExperimental study·DateFeb 17, 2025

Common drug shows promise against rare type of heart disease

A team of researchers from the University of Arizona College of Medicine – Tucson found that an FDA-approved osteoporosis treatment, risedronate, can correct a gene mutation and normalize heart function in animal models. The study provides hope for treating other rare diseases using precision treatments tailored to individual mutations.

SourceUniversity of Arizona Health Sciences·JournalJournal of Clinical Investigation·TypeExperimental study·DateFeb 17, 2025

A simple supplement improves survival in patients with a new type of heart disease

A study published in Nature Cardiovascular Research found that tricaprin improved long-term survival and recovery from heart failure in patients with triglyceride deposit cardiomyovasculopathy. The supplement reversed structural changes and improved heart muscle function, leading to higher survival rates compared to controls.

SourceOsaka University·JournalNature Cardiovascular Research·TypeObservational study·DateFeb 13, 2025

Type 1 diabetes: Hybrid closed-loop and open-loop systems compared

A study comparing hybrid closed-loop and open-loop systems in young people with type 1 diabetes found that hybrid closed-loop systems offered improved long-term blood sugar values, a lower risk of hypoglycemic coma, but a higher rate of diabetic ketoacidosis. The results suggest that hybrid closed-loop therapies may be beneficial for i...

SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalThe Lancet Diabetes & Endocrinology·TypeObservational study·DateFeb 12, 2025

Mystery solved: New study reveals how DNA repair genes play a major role in Huntington's disease

Researchers discovered that mismatch repair genes are critical in eliciting damages to neurons vulnerable to Huntington's disease, triggering downstream pathologies and motor impairment. Targeting these genes may offer novel therapeutic approaches, including improving locomotor and gait deficits and reducing neuronal cell death.

E64FC26, a protein disulfide isomerase inhibitor, ameliorates articular cartilage damage and disease severity in a mouse model of rheumatoid arthritis

A study investigates the efficacy of EFC as a potential treatment for RA, showing anti-inflammatory effects on fibroblast-like synoviocytes and alleviating disease severity in animal models. The findings highlight the therapeutic potential of PDIs in RA management.

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateFeb 10, 2025

CNIC scientists design an effective treatment strategy to prevent heart injury caused by a class of anticancer drugs

Researchers at the CNIC have designed a treatment strategy to protect the heart against cardiotoxic effects of anthracyclines, a common class of anticancer drugs. Empagliflozin, an SGLT2 inhibitor, has been shown to preserve cardiac function and metabolism in experimental models.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalJACC CardioOncology·TypeExperimental study·DateFeb 4, 2025

New ACP guideline on migraine prevention shows no clinically important advantages for newer, expensive medications

The American College of Physicians recommends preventing episodic migraines with monotherapy, including beta-adrenergic blockers and antiseizure medications. However, a comparative effectiveness systematic review found no significant differences in clinical net benefit among treatments.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateFeb 3, 2025

Longitudinal analysis of obesity drug use and public awareness

The study found a significant increase in obesity drug prescriptions from 0.76 million in July 2017 to 1.5 million in February 2024, mirroring rising public online search activity for semaglutide and tirzepatide. This correlation highlights the real-time association between public awareness and prescription trends.

SourceJAMA Network·JournalJAMA Network Open·DateJan 29, 2025

Cell death and aging in cancer research review

A review of cell death and aging in cancer research reveals the significance of cellular senescence in promoting cancer growth. The study highlights the potential of various types of programmed cell death, such as necroptosis and pyroptosis, as therapeutic targets against senescent cells.

SourceOsaka Metropolitan University·JournalSeminars in Cancer Biology·TypeLiterature review·DateJan 28, 2025

The Terasaki Institute for Biomedical Innovation partners with the Technology Innovation Institute to further drug discovery and disease modeling in neurology

The collaboration aims to develop advanced 3D mini-brain models for replicating human brain architecture, enabling researchers to explore neurological diseases and screen drug candidates. The platform offers a high-throughput screening method for rapid testing of potential drug candidates.